Literature DB >> 17526975

High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk.

Kunihiro Matsushita1, Hiroshi Yatsuya, Koji Tamakoshi, Pei Ou Yang, Rei Otsuka, Keiko Wada, Hirotsugu Mitsuhashi, Yo Hotta, Takahisa Kondo, Toyoaki Murohara, Hideaki Toyoshima.   

Abstract

BACKGROUND: Although numerous studies have demonstrated a positive association of high-sensitivity C-reactive protein (CRP) with the incidence of coronary heart disease (CHD), little information exists regarding this issue in Japanese. METHODS AND
RESULTS: The association between CRP and the Framingham Risk Score (FRS) was investigated in 2,523 middle-aged Japanese men without a medical history of CHD. CRP was significantly associated with this score obtained from all FRS factors. After dividing subjects into 4 categories of relative risk estimate for CHD, the geometric mean of CRP (mg/L) increased gradually with the CHD risk (below average: 0.39 [95% confidence interval, 0.37-0.41], average: 0.58 [0.50-0.67], moderately above average: 0.70 [0.57-0.86], high: 0.79 [0.58-1.09], trend p<0.001). However, it should be noted that the mean CRP concentration of the high-risk group was only 0.79 mg/L and a greater proportion (63.8%) of the high-risk subjects was in the low-risk range of CRP (<1 mg/L).
CONCLUSIONS: Circulating CRP well reflect the estimated CHD risk, indicating that CRP may be useful for coronary risk stratification in Japanese also. However, the details of the CRP level in Japanese must be investigated further by prospective studies to determine the Japanese-specific cutoff points for CHD risk evaluation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526975     DOI: 10.1253/circj.71.820

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  10 in total

1.  High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome), including nonalcoholic steatohepatitis.

Authors:  Eiji Oda; Kenichi Watanabe
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

2.  Low serum level of high-sensitivity C-reactive protein in a Japanese patient with maturity-onset diabetes of the young type 3 (MODY3).

Authors:  Tsuyoshi Ohki; Yoshihiko Utsu; Shinya Morita; Md Fazlul Karim; Yoshifumi Sato; Tatsuya Yoshizawa; Ken-Ichi Yamamura; Kentaro Yamada; Soji Kasayama; Kazuya Yamagata
Journal:  J Diabetes Investig       Date:  2014-04-10       Impact factor: 4.232

3.  High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study.

Authors:  An Pan; Yeli Wang; Jian-Min Yuan; Woon-Puay Koh
Journal:  BMC Endocr Disord       Date:  2017-02-08       Impact factor: 2.763

4.  The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Reduces Aortic Damage from Hypercholesterolaemia in Apolipoprotein E-Deficient Mice.

Authors:  Ying Zhang; Nan Wang; Liyue Zhu; Yingshu Liu; Zuowei Pei; Guan Wang; Lin Luo; Hongyang Liu
Journal:  Biomed Hub       Date:  2017-05-20

5.  Effects of thymoquinone against angiotensin II‑induced cardiac damage in apolipoprotein E‑deficient mice.

Authors:  Lei Zhang; Hujin Zhang; Jing Ma; Yun Wang; Zuowei Pei; Hui Ding
Journal:  Int J Mol Med       Date:  2022-03-16       Impact factor: 4.101

Review 6.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06

7.  Central obesity and smoking are key modifiable risk factors for elevated C-reactive protein in Asian individuals who are not eligible for statin therapy.

Authors:  C M Khoo; M Tan; Y Wu; C H Wai; T Subramaniam; J Lee; E S Tai
Journal:  Nutr Diabetes       Date:  2011-05-23       Impact factor: 5.097

8.  Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice.

Authors:  Jingyi Xu; Liyue Zhu; Hongyang Liu; Mengye Li; Yingshu Liu; Fan Yang; Zuowei Pei
Journal:  Lipids Health Dis       Date:  2018-07-26       Impact factor: 3.876

9.  Thymoquinone Protects against Hyperlipidemia-Induced Cardiac Damage in Low-Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice via Its Anti-inflammatory and Antipyroptotic Effects.

Authors:  Zuo-Wei Pei; Ying Guo; Huo-Lan Zhu; Min Dong; Qian Zhang; Fang Wang
Journal:  Biomed Res Int       Date:  2020-10-29       Impact factor: 3.411

10.  Reduction in hsCRP levels is associated with decreased incidence of cardiovascular events in Japanese hypertensive women but not in men.

Authors:  Shokei Kim-Mitsuyama; Hirofumi Soejima; Osamu Yasuda; Koichi Node; Hideaki Jinnouchi; Eiichiro Yamamoto; Taiji Sekigami; Hisao Ogawa; Kunihiko Matsui
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.